Clinical Trial Update: MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MRG-001 as an immunoregulatory and regenerative therapy for Acute Respiratory Distress Syndrome; the trial is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• MRG-001

Snippet

Sponsor: MedRegen LLC | Conditions: Acute Respiratory Distress Syndrome, Respiratory Failure | Phase 2 | Status: NOT_YET_RECRUITING